explore -WSS

explore

author：Wikipedia 2025-09-30 16:23:23 - browse：6893

Capitol Riot Maine — FILE - Violent rioters supporting President Donald Trump storm the Capitol in Washington, Wednesday, Jan. 6, 2021. A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday, July 21, 2023, and charged with federal crimes for his role in the U.S. Capitol riot, officials said. (AP Photo/John Minchillo, File)The Associated Press

PORTLAND, Maine -- A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday and charged with federal crimes for his role in the U.S. Capitol riot, officials said.

Matthew Brackley, 39, of Waldoboro, Maine, entered the the Capitol on Jan. 6, 2021, and asked for the location of House Speaker Nancy Pelosi’s office before shouting, “Let’s go," according to prosecutors.

He was arrested on felony charges including assaulting, resisting or impeding certain officers and civil disorder, along with several misdemeanors. He made his initial court appearance on Friday.

It was not clear if Brackley had a lawyer, and he did not immediately respond to an email request for comment.

Brackley tried unsuccessfully to unseat Democratic state Sen. Eloise Vitelli of Arrowsic last year. His campaign website described him as a Maine Maritime Academy graduate whose approach would be to have “respectful, thoughtful conversations on the issues.”

At the Capitol, prosecutors said, Brackley led a group that pushed through police officers several times before ultimately being dispersed by chemical spray and exiting.

More than 1,000 people have been charged with federal crimes related to the Jan. 6 attack.

Approximately 100 of them have been convicted by juries or judges after trials, and more than 600 have pleaded guilty.

Over 570 riot defendants have been sentenced, with more than half receiving prison terms ranging from three days to 18 years.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Pregnancy discrimination could be enabled by AI

WSS

Why sickle cell disease is getting the first CRISPR treatment

Patients' immediate access to test results puts radiologists in a bind

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Radiology is caught between AI's potential and concern for patients

Cheap, fast test for Zika and dengue could cost just $1

FDA needs staff influx to meet gene therapy needs, Marks says

focus

explore

entertainment

Sports medicine is finally prioritizing gender equality

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Moonlake's readout produced a cash windfall. Risks remain

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Medical records are filled with copy

What PEPFAR has meant on the ground in Ukraine

Medical leaders decry Supreme Court decision on affirmative action

Pharma patents targeted by Biden in move to slash drug prices

New air purifier tech could be key to improving indoor air quality

Cigna wins case to block Amy Bricker's move to CVS

leisure time

Medical device trials still don't enroll enough women, study finds

California wildfire smoke linked to 52,000 early deaths, study says

The system is set up to fail children with medical complexity

My daughter's legacy lives on through her writing, phage therapy

Congenital heart disease patients face new threat of heart failure

Pharma companies must ensure equitable access to obesity drugs

hotspot

knowledge

focus

leisure time